Begin main content

Open Calls for Patient Input

This page lists Common Drug Review (CDR) drug applications received by CADTH and the deadlines for filing patient group input for each drug. For more information about how to provide input, please visit the CDR Patient Input page

Olumiant (baricitinib)

Indications: Arthritis, Rheumatoid

Call For Patient Input: November 22, 2018

Patient Input Closed: January 18, 2019

TBC (filgrastim)

Indications: neutropenia, blood cell mobilization (various indications)

Call For Patient Input: November 19, 2018

Patient Input Closed: January 15, 2019

Cystadrops (cysteamine)

Indications: Corneal cystine crystal deposits

Call For Patient Input: November 2, 2018

Patient Input Closed: December 20, 2018

Ozempic (semaglutide)

Indications: Diabetes mellitus, type 2

Call For Patient Input: October 26, 2018

Patient Input Closed: December 14, 2018